Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation. [electronic resource]
Producer: 20200714Description: e011112 p. digitalISSN:- 2047-9980
- Administration, Oral
- Aged
- Aged, 80 and over
- Anticoagulants -- administration & dosage
- Antithrombins -- administration & dosage
- Atrial Fibrillation -- diagnosis
- Dabigatran -- administration & dosage
- Female
- Hemorrhage -- chemically induced
- Humans
- Liver Cirrhosis -- diagnosis
- Male
- Middle Aged
- Patient Safety
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Retrospective Studies
- Risk Assessment
- Risk Factors
- Rivaroxaban -- administration & dosage
- Stroke -- diagnosis
- Taiwan -- epidemiology
- Thromboembolism -- diagnosis
- Time Factors
- Treatment Outcome
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.